FDA OKs independent review of FzioMed's spinal surgery gel

11/5/2013 | MassDevice.com (Boston)

The FDA has authorized an independent review of FzioMed's premarket approval application for Oxiplex, a gel product designed to help lower-back spinal surgery patients heal. The review, which will be conducted by a Medical Devices Dispute Resolution Panel, will consider the case and provide advice to FDA Commissioner Dr. Margaret Hamburg about whether she should reverse the FDA's 2008 decision to refuse the device's PMA.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC